coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Wb PCN, Woking · Health Inequalities Profile

    PCN U67304 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    30,294

    Registered population

    58.2% aged 18–64

    21.8%

    Aged 65+

    ICB 18.8% · England 17.9%

    14.2%

    Ethnic minority (non-White)

    8.6% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    4,209

    Hypertension register

    +6.54% in 3 yrs · England +5.60%

    209

    SMI register

    20.8% of Woking's

    372

    COPD register

    Reviews +3.99% in 3 yrs

    Forecast to 2030

    5,026

    Hypertension patients, 2030

    +817 on today

    57.2%

    QRISK ≥20% on statins, 2030

    +1.89pp over 3 yrs

    5.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    53.2%
    High-risk lipid therapy trails national and local benchmarks.

    Lipid therapy for QRISK >= 20% is 10.3 percentage points below England's 63.6% (Woking 61.7%) and 64.2% in CKD, which may reflect recall gaps.

    -3.1%
    COPD register fell while national prevalence rose.

    COPD prevalence fell over 2023 to 2025 (England +2.6%) to 1.2% (England 1.9%), an unadjusted benchmark range up to 202 patients that could reflect.

    75.3%
    Hypertension control and annual reviews exceed benchmarks.

    Hypertension treatment to target exceeds England's 70.3% (ICB 71.4%), alongside 84.4% COPD reviews (England 76.4%) and 88.8% SMI blood pressure checks (England 83.4%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65 and over reach 21.8%, exceeding borough and national levels

    WB PCN covers 30,294 registered patients across three practices. Patients aged 65 and over account for 21.8% (6,616 patients), higher than Woking (15.3%), NHS Surrey Heartlands Integrated Care Board (18.8%) and England (17.9%). Those aged 18-64 make up 58.2% (Woking 63.4%, ICB 60.8%, England 62.7%), and children aged 0-17 represent 20.0% (Woking 21.3%, ICB 20.4%, England 19.6%). Based on Census usual residents rather than registered patients, White groups comprise 85.8% (Woking 78.4%, ICB 85.3%, England 81.1%) and Asian groups 8.6% (Woking 14.2%, ICB 7.7%, England 9.6%).

    Age profile

    0–1720.0%
    18–6458.2%
    65+21.8%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White85.8%
    Asian8.6%
    Mixed3.1%
    Other1.6%
    Black0.9%

    Older people · falls rows are Woking local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Woking LA)1,8542,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.8%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)62.3%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Woking LA)7969819552024/25
    Falls deaths, all ages, per 100,000 (Woking LA)11.214.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Average IMD decile is 8.4 with 0.0% of registered patients in Core20

    WB PCN records an average IMD decile of 8.4, less deprived than Woking (7.8), NHS Surrey Heartlands Integrated Care Board (7.9), and England (5.5). Average IMD is 8.6 at Madeira Medical, 8.2 at Parishes Bridge Med.pract, and 8.2 at Wey Family Practice. Registered patients in Core20 stand at 0.0% across all three practices (Woking 1.5%, ICB 0.8%, England 21.0%), and estimated Core20 residents total 0. Zero Core20 concentration suggests health equity reviews could focus on inclusion health and individual vulnerability rather than area deprivation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Madeira Medical0.0% · 0 patients
    Parishes Bridge0.0% · 0 patients
    Wey0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    209

    SMI register

    0.67% recorded prevalence

    117

    Learning disability register

    0.38% recorded prevalence

    14

    Care homes, 525 beds

    In the PCN catchment

    8.3%

    Provide unpaid care

    Woking, Census 2021

    The PCN records 209 patients on the severe mental illness register (0.7% vs Woking 0.8%, NHS Surrey Heartlands Integrated Care Board 0.8%, England 1.0%) and 117 on the learning disability register (0.4% vs Woking 0.5%, ICB 0.5%, England 0.6%), alongside 14 catchment care homes with 525 beds. Lower crude recorded prevalence does not establish under-detection; clinical audits could examine whether differences reflect coding practice or true prevalence.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 0.7% (209 patients). Recorded checks exceed England: blood pressure reached 88.8% (England 83.4%), BMI reached 90.9% (England 82.1%), and alcohol status recording in psychosis reached 89.3% (England 81.8%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    4,209

    Hypertension register

    +6.54%

    Register growth, 3 yrs

    Woking +6.51% · England +5.60%

    +1.64pp

    BP control, under 80

    ≤140/90 · +1.64pp aged 80+

    +817

    More patients by 2030

    Forecast 5,026 (15.38%)

    Hypertension case-finding and control

    Hypertension prevalence is 13.6% (4,209 patients), against 13.2% in Woking, 14.3% in NHS Surrey Heartlands Integrated Care Board, and 15.2% in England. Recent blood pressure checks reach 92.6% (England 90.0%) and treatment to target is 75.3% (England 70.3%), including 72.6% under 80 and 84.3% aged 80+. Over 2023 to 2025, treatment to target grew +0.8% (England +3.6%). Among patients aged 80+, blood pressure control is 78.2% at Wey Family Practice and 90.0% at Madeira Medical. Lower recorded prevalence than England does not establish undiagnosed disease, but practice-level variation among older patients could be audited locally.

    Lipids and statins

    Lipid-lowering therapy reaches 53.2% for QRISK ≥ 20% patients (Woking 61.7%, NHS Surrey Heartlands Integrated Care Board 59.4%, England 63.6%) and 64.2% for CKD patients (England 70.3%). Lower therapy rates across high-risk groups may reflect differences in recall protocols, which practice audits could review.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202634,489£2.70£2.24£1.86£93,120
    Cardiovascular (all), 202549,607£4.91£4.74£3.33£243,570

    For lipid-regulating drugs 2026, cost per item is £2.70 across 34,489 prescribed items, compared to £2.50 in Woking, £2.24 in NHS Surrey Heartlands Integrated Care Board, and £1.86 in England. This equates to £28,971 more than at England's unit cost. Higher unit cost than comparators may reflect prescribing mix, which a review of local formulary choices could explore.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +11.80%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +5.13%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 1.2% (372 patients), matching Woking (1.2%) and below England (1.9%), with a 3-year change of -3.1% over 2023 to 2025 (England +2.6%). Annual COPD reviews reach 84.4% (England 76.4%). Asthma prevalence is 5.1% (1,501 patients; England 6.6%), while annual reviews reach 70.9% (England 65.7%), leaving an estimated gap of about 440 unreviewed patients. Asthma management items for ages 5–19 rate at 787 per 1,000 (England 1,488).

    Cancer register and children's immunisation

    Cancer register prevalence is 4.6% (1,434 patients; England 3.8%). In Q1 2025/26 childhood immunisations, 6-in-1 completion at 24 months was 100.0% and MMR dose 1 was 96.7%, both meeting the 95.0% target. At age 5, MMR dose 1 is 94.3%, MMR dose 2 is 88.6% (5.7 pp below dose 1), and 4-in-1 booster coverage is 87.1%. Lower age-5 coverage could reflect recall timing, which a preschool vaccination audit would evaluate.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.7%

    England 91.0%

    6-in-1 complete primary course at 24 months100.0%

    England 92.2%

    MMR dose 1 at 24 months96.7%

    England 88.3%

    MMR dose 2 at age 588.6%

    England 82.8%

    4-in-1 pre-school booster at age 587.1%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    Across NHS Surrey Heartlands ICB in 2022, 61.4% of cancers with a known stage (2,955 of 4,810) were diagnosed at stage 1 or 2, exceeding England's 55.3% but sitting 13.6 pp below the 75.0% national ambition by 2028, requiring about 650 extra early-stage diagnoses across the ICB. Known-stage coverage was 67.7% (4,810 of 7,106 cancers; England 67.0%). Early staging reached 88.2% in breast but 48.1% in bowel. Within WB PCN, cervical screening reached 71.4% (England 66.8%), falling 2.3% over 2023 to 2025 (England -1.0%), with Parishes Bridge Med.pract at 67.5%. While ICB early staging exceeds the national rate, trailing screening trends could delay diagnosis without proactive recall.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    For July 2026 (provisional), Ashford and St Peter's Hospitals NHS Foundation Trust met the 28-day faster diagnosis standard at 85.5% (above the 75.0% standard; England 79.3%; Royal Surrey NHS Foundation Trust 82.6%; Frimley Health NHS Foundation Trust 87.9%). However, 62-day referral to treatment was 76.4%, below the 85.0% standard by 8.6 pp (England 71.2%; NHS Surrey and Sussex Integrated Care Board 71.5%; Royal Surrey NHS Foundation Trust 84.5%). Across all diagnostic tests, 23.1% waited 6+ weeks (England 23.1%; Frimley Health NHS Foundation Trust 7.5%), with colonoscopy reaching 49.6% and gastroscopy 56.7%. Provider diagnostic delays could reflect endoscopy backlogs before treatment.

    Pathways within standard (%)Ashford and St Peter'sRoyal SurreyFrimley HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)85.5382.6287.9579.2979.32
    31-day treatment (96%)94.2196.4392.8990.4592.50
    62-day referral to treatment (85%)76.3884.4881.8471.5171.16
    Diagnostic waits over 6 weeks (%)Ashford and St Peter'sRoyal SurreyFrimley HealthEngland
    MRI0.090.0012.8521.40
    CT9.270.150.639.92
    Echocardiography0.971.553.3528.48
    Colonoscopy49.610.0022.8430.83
    Gastroscopy56.740.007.4329.02
    All 15 DM01 tests23.128.827.4923.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In June 2026 (provisional), Surrey residents accounted for 109,530 community care contacts and 66,060 community care activities, while NHS Surrey and Sussex Integrated Care Board recorded 309,615 contacts. Adults aged 65+ made up 69.6% of contacts with residents (76,215 of 109,530). These figures represent experimental submitting-provider activity rather than PCN patient volume. Community service use could reflect high older adult care needs across the borough.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access varies by 31.5 percentage points alongside wide overall satisfaction spreads

    In 2025/26, overall QOF achievement spanned 92.2% at Parishes Bridge Med.pract to 98.8% at Madeira Medical (England 92.5%). Vaccination achievement ranged 16.9 percentage points, from 74.2% at Wey Family Practice to 91.1% at Parishes Bridge Med.pract. Personalised care adjustments were 5.0% at Madeira Medical, and 9.2% at both Parishes Bridge Med.pract and Wey Family Practice.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Wey1020.062.6%68.1%88.4%
    Madeira Medical970.065.4%79.7%79.8%
    Parishes Bridge830.033.9%79.2%59.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNWokingAssetPCNWoking
    Care homes (catchment)14 (525 beds)n/aSchools (catchment)25n/a
    Children's centres28Places of worship1249
    Libraries31Homelessness support (VCS)0no data
    Day centres (VCS)n/a2Carers support groups (VCS)n/a1
    Primary schools (LA maintained)12Primary academies419
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    High-risk cardiovascular lipid therapy review

    Lipid therapy for QRISK >= 20% is 53.2%, below England (63.6%) by 10.3 pp and Woking (61.7%) by 8.5 pp, while CKD lipid therapy is 64.2% (England 70.3%). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    COPD register case-finding and audit

    COPD prevalence is 1.2% (372 patients) against 1.9% in England and 1.2% in Woking, giving an unadjusted benchmark range of -16 to +202 patients. For discussion, practices could search records for smokers or patients with repeated respiratory prescribing lacking a COPD code and raise spirometry access with system partners. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Learning disability register coding validation

    Learning disability register prevalence is 0.4% (117 patients) versus 0.5% in Woking and 0.6% in England, giving an unadjusted range of +32 to +61 patients. For discussion, practices could audit clinical records for historic learning disability codes and cross-check lists where social-care data sharing exists. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult care coordination (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Severe mental illness register review (p4)Severe mental illness: QOF prevalenceMHIS · From Harm to HopePCN
    Older cohort hypertension review (p5)Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029Practice
    Preschool immunisation recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake and recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · High-risk cardiovascular lipid therapy review (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · CKD patients treated with lipid lowering therapy · Hypertension registerCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Option 2 · COPD register case-finding and audit (p12)COPD register · COPD: QOF prevalenceCore20PLUS5 approach · Tobacco and Vapes BillPCN
    Option 3 · Learning disability register coding validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15